文献速递类风湿关节炎

FPGS前体mRNA剪接改变与早期类风湿关节炎甲氨蝶呤无应答相关

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

结果发现,基线8PR/8WT比值较高与13周和26周DAS44较高相关,并趋于或与未达到低疾病活动度及EULAR无应答相关。

要点

  • 基线FPGS 8PR/8WT比值高与COBRA-light组13周和26周DAS44较高显著相关。
  • 基线8PR/8WT比值高与COBRA组26周DAS44较高及无应答显著相关。
  • FPGS前体mRNA剪接改变是RA患者MTX应答降低的相关因素。

核心结论

  • FPGS前体mRNA剪接水平改变与RA患者对MTX治疗应答降低相关。

研究设计与样本

  • 在基线、13周和26周采集血样,用RT-qPCR检测FPGS 8PR与野生型FPGS(8WT)的RNA比值。

主要发现

  • COBRA-light组基线8PR/8WT比值较高与13周和26周DAS44较高显著相关。
  • COBRA-light组基线8PR/8WT比值较高趋于未达到低疾病活动度(DAS<1.6)及13周和26周EULAR无应答。
  • COBRA组基线8PR/8WT比值高与26周DAS44较高显著相关。
  • COBRA组8PR/8WT比值较高与26周基于低疾病活动度和EULAR标准的无应答相关。

关键数值与推荐

  • 低疾病活动度定义为DAS<1.6。
  • 应答评估采用EULAR标准。
  • 疾病活动度采用44关节疾病活动度评分(DAS44)。

临床怎么用

  • 基线FPGS 8PR/8WT比值或可作为早期RA患者MTX应答的潜在生物标志物。
  • 对基线8PR/8WT比值较高的RA患者,需更密切监测疾病活动度并及时评估治疗方案。

局限性

  • 样本量较小,COBRA-light组21例、COBRA组15例。
  • 部分关联仅为趋势性结果,未达到统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: An efficient pharmacological response to MTX treatment in RA patients relies on the retention and accumulation of intracellular MTX-polyglutamates catalysed by the enzyme folylpolyglutamate synthetase (FPGS). We recently identified a partial retention of FPGS intron 8 (8PR) as a prominent splice variant conferring FPGS dysfunction and decreased MTX polyglutamylation in acute lymphoblastic leukaemia. Here, we explored the association between FPGS 8PR levels and lack of MTX responsiveness in RA patients. METHODS: Thirty-six patients undergoing MTX treatment were enrolled from the Combinatie behandeling Reumatoide Artritis (COBRA)-light trial. RNA was isolated from blood samples at baseline, 13 weeks and 26 weeks of therapy, from patients in either COBRA-light (n = 21) or COBRA (n = 15) treatment arms. RT-qPCR analysis was used to assess RNA levels of FPGS 8PR over wild-type FPGS (8WT). RESULTS: In the COBRA-light treatment arm, higher baseline ratios of 8PR/8WT were significantly associated with higher 44-joint disease activity score (DAS44) at 13 and 26 weeks. Higher baseline ratios of 8PR/8WT also trended towards not obtaining low disease activity (DAS <1.6) and becoming a EULAR non-responder at 13 and 26 weeks. In the COBRA-treatment arm, a significant association was observed between high baseline 8PR/8WT ratios and higher DAS44 score at 26 weeks. Higher 8PR/8WT ratios were associated with non-response at week 26 based on both low disease activity and EULAR criteria. CONCLUSION: This study is the first to associate alterations in FPGS pre-mRNA splicing levels with reduced responsiveness to MTX treatment in RA patients. TRIAL REGISTRATION: ISRCTN55552928.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Muller IB, Lin M, Lems WF, et al. Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 32940699. doi:10.1093/rheumatology/keaa428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。